Japan, June 25 -- ABLYNX NV has got intellectual property rights for 'METHODS OF TREATING TTP WITH IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND USES THEREOF.' Other related details are as follows:
Application Number: JP,2022-110921
Category (FI): A61K39/395@N,A61K39/395@D,A61P9/10,C07K16/36
Stage: Grant (IP right granted following substantive examination.)
Filing Date: July 11, 2022
Publication Date: Oct. 19, 2022
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....